Filing Details
- Accession Number:
- 0000899243-20-005836
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-25 20:10:19
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-25 20:10:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1261249 | Agile Therapeutics Inc | AGRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1164426 | Joseph Edelman | C/O Perceptive Advisors Llc 51 Astor Place, 10Th Floor New York NY 10003 | No | No | Yes | No | |
| 1224962 | Perceptive Advisors Llc | 51 Astor Place, 10Th Floor New York NY 10003 | No | No | Yes | No | |
| 1249675 | Ltd Fund Master Sciences Life Perceptive | C/O Perceptive Advisors Llc 51 Astor Place, 10Th Floor New York NY 10003 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-25 | 3,000,000 | $3.00 | 14,919,925 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants (right to buy) | Acquisiton | 2020-02-10 | 700,000 | $0.00 | 700,000 | $3.74 |
| Common Stock | Warrants (right to buy) | Acquisiton | 2020-02-10 | 700,000 | $0.00 | 700,000 | $4.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 700,000 | 2020-02-10 | 2027-02-10 | No | 4 | J | Indirect |
| 700,000 | 2020-02-10 | 2027-02-10 | No | 4 | J | Indirect |
Footnotes
- The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor.
- The securities were acquired by Perceptive Credit Holdings III, L.P. (the "Credit Fund") in connection with a senior secured term loan credit facility entered into with the Issuer.
- The securities are directly held by the Credit Fund. The Advisor serves as the investment manager of the Credit Fund. Mr. Edelman is the managing member of the Advisor.
- Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Billionaire Hedge Funds
